Integrative Perspectives on Neurodegeneration and Aging: From Molecular Insights to Therapeutic Strategies

References

1. Bhaskar R. Circadian rhythm, metabolism, and neurodegeneration: mechanisms and interventions. Curr. Alzheimer Res. 2025 10.2174/0115672050381989250626071304
   [Google Scholar]
2. Chauhan B.S. Singh Y.P. Poeggeler B. Singh S.K. Therapeutic advances in Alzheimer’s disease: Integrating natural, semi-synthetic, and synthetic drug strategies. Curr. Alzheimer Res. 2025 22 1 17 10.2174/0115672050366727250513061730 40454492
   [Google Scholar]
3. Algantri K.R. Neuroprotective agents: Implications for Parkinson’s disease treatment. Curr. Alzheimer Res. 2025 1 27 10.2174/0115672050368080250529075006
   [Google Scholar]
4. Singh A. Sethi P. Ghosh S. Current status of prevention strategies adapted for Alzheimer’s disease. In: A new era in Alzheimer’s research: Pathogenesis, prevention, and treatment. Academic Press 2025 91 108 10.1016/B978‑0‑443‑15540‑6.00004‑5
   [Google Scholar]
5. Mishra P.K. Ghosh S. Singh K.K. Sinha J.K. Physical exercise and lifestyle management: Preventive measures for Alzheimer’s disease. In: A new era in Alzheimer’s Research: Pathogenesis, prevention, and treatment. Academic Press 2025 169 182 10.1016/B978‑0‑443‑15540‑6.00003‑3
   [Google Scholar]
6. Sachdeva P. Narayanan K.B. Sinha J.K. Recent advances in drug delivery systems targeting insulin signalling for the treatment of Alzheimer’s Disease. J. Alzheimers Dis. 2024 98 4 1169 1179 10.3233/JAD‑231181 38607755
   [Google Scholar]
7. Vashisth K. Sharma S. Ghosh S. Immunotherapy in Alzheimer’s disease: Current status and future directions. J. Alzheimers Dis. 2024 101 s1 S23 S39 10.3233/JAD‑230603 39422934
   [Google Scholar]
8. Bano S. Raza M.A. Ghosh S. Emerging therapeutic targets in molecular neuropharmacology for Alzheimer’s Disease. J. Biol. Regul. Homeost. Agents 2023 37 11 5769 5784 10.23812/j.biol.regul.homeost.agents.20233711.553
   [Google Scholar]
9. Ghosh S. Sachdeva B. Sachdeva P. Chaudhary V. Rani G.M. Sinha J.K. Graphene quantum dots as a potential diagnostic and therapeutic tool for the management of Alzheimer’s disease. Carbon Letters 2022 32 6 1381 1394 10.1007/s42823‑022‑00397‑9
   [Google Scholar]
10. Mishra P. Mittal A.K. Kalonia H. SIRT1 promotes neuronal fortification in neurodegenerative diseases through attenuation of pathological hallmarks and enhancement of cellular lifespan. Curr. Neuropharmacol. 2021 19 7 1019 1037 10.2174/18756190MTA44NjIg1 32727328
    [Google Scholar]
11. Sethi P. Bhaskar R. Singh K.K. Exploring advancements in early detection of Alzheimer’s disease with molecular assays and animal models. Ageing Res. Rev. 2024 100 102411 10.1016/j.arr.2024.102411 38986845
    [Google Scholar]
12. Sethi P. Singh K.K. Amist A.D. Molecular and neuroimaging biomarkers in the diagnosis of Alzheimer’s disease. In: A new era in Alzheimer’s research: Pathogenesis, prevention, and treatment. Academic Press 2025 51 65 10.1016/B978‑0‑443‑15540‑6.00006‑9
    [Google Scholar]
13. Ghosh S. Durgvanshi S. Agarwal S. Raghunath M. Sinha J.K. Current status of drug targets and emerging therapeutic strategies in the management of Alzheimer’s Disease. Curr. Neuropharmacol. 2020 18 9 883 903 10.2174/1570159X18666200429011823 32348223
    [Google Scholar]